Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Castle Biosciences disclosed the grant of 204,925 restricted stock units to 172 new employees. The grants were made on June 15, 2026, pursuant to the company's 2022 Inducement Plan and Nasdaq Listing Rule 5635(c)(4).
Key figures
- Shares granted
- 204925
- Employees granted
- 172
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.